124 related articles for article (PubMed ID: 9369427)
1. Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells.
Semichon M; Merle-Béral H; Lang V; Bismuth G
Leukemia; 1997 Nov; 11(11):1921-8. PubMed ID: 9369427
[TBL] [Abstract][Full Text] [Related]
2. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
[TBL] [Abstract][Full Text] [Related]
3. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling.
Kurosaki T; Takata M; Yamanashi Y; Inazu T; Taniguchi T; Yamamoto T; Yamamura H
J Exp Med; 1994 May; 179(5):1725-9. PubMed ID: 7513017
[TBL] [Abstract][Full Text] [Related]
4. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
[TBL] [Abstract][Full Text] [Related]
5. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
Feng G; Wang X
Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
[TBL] [Abstract][Full Text] [Related]
6. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells.
Lankester AC; van Schijndel GM; van der Schoot CE; van Oers MH; van Noesel CJ; van Lier RA
Blood; 1995 Aug; 86(3):1090-7. PubMed ID: 7620163
[TBL] [Abstract][Full Text] [Related]
7. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
8. Activation of syk in an immature B cell line does not require lyn activity.
Muthukkumar S; Venkataraman C; Woods T; Bondada S
Mol Immunol; 1997; 34(12-13):865-75. PubMed ID: 9464522
[TBL] [Abstract][Full Text] [Related]
9. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.
Law CL; Sidorenko SP; Chandran KA; Zhao Z; Shen SH; Fischer EH; Clark EA
J Exp Med; 1996 Feb; 183(2):547-60. PubMed ID: 8627166
[TBL] [Abstract][Full Text] [Related]
10. Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling.
Kurosaki T; Johnson SA; Pao L; Sada K; Yamamura H; Cambier JC
J Exp Med; 1995 Dec; 182(6):1815-23. PubMed ID: 7500027
[TBL] [Abstract][Full Text] [Related]
11. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
13. Cross-linking of B cell antigen receptor-related structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of phosphatidylinositol 3-kinase.
Kuwahara K; Kawai T; Mitsuyoshi S; Matsuo Y; Kikuchi H; Imajoh-Ohmi S; Hashimoto E; Inui S; Cooper MD; Sakaguchi N
Int Immunol; 1996 Aug; 8(8):1273-85. PubMed ID: 8918697
[TBL] [Abstract][Full Text] [Related]
14. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
Palomba ML; Piersanti K; Ziegler CG; Decker H; Cotari JW; Bantilan K; Rijo I; Gardner JR; Heaney M; Bemis D; Balderas R; Malek SN; Seymour E; Zelenetz AD; van den Brink MR; Altan-Bonnet G
PLoS One; 2014; 9(1):e79987. PubMed ID: 24489640
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation and association of Syk with Fc gamma RII in monocytic THP-1 cells.
Ghazizadeh S; Bolen JB; Fleit HB
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):669-74. PubMed ID: 7530449
[TBL] [Abstract][Full Text] [Related]
16. Rapid desensitization of B-cell receptor by a dithiol-reactive protein tyrosine phosphatase inhibitor: uncoupling of membrane IgM from syk inhibits signals leading to Ca2+ mobilization.
Rozsnyay Z; Sarmay G; Gergely J
Immunol Lett; 1995 Jan; 44(2-3):149-56. PubMed ID: 7541023
[TBL] [Abstract][Full Text] [Related]
17. Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.
Song Z; Lu P; Furman RR; Leonard JP; Martin P; Tyrell L; Lee FY; Knowles DM; Coleman M; Wang YL
Clin Cancer Res; 2010 Jan; 16(2):587-99. PubMed ID: 20068106
[TBL] [Abstract][Full Text] [Related]
18. Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.
Hoellenriegel J; Coffey GP; Sinha U; Pandey A; Sivina M; Ferrajoli A; Ravandi F; Wierda WG; O'Brien S; Keating MJ; Burger JA
Leukemia; 2012 Jul; 26(7):1576-83. PubMed ID: 22362000
[TBL] [Abstract][Full Text] [Related]
19. CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase.
Silvennoinen O; Nishigaki H; Kitanaka A; Kumagai M; Ito C; Malavasi F; Lin Q; Conley ME; Campana D
J Immunol; 1996 Jan; 156(1):100-7. PubMed ID: 8598449
[TBL] [Abstract][Full Text] [Related]
20. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
